Protecting a blockbuster diabetes treatment for AstraZeneca
AstraZeneca AB
Major victories across IP venues for Volkswagen, Audi, Bentley, and Lamborghini
Audi AG; Audi of America, LLC; Automobili Lamborghini America, LLC; Automobili Lamborghini S.p.A.; Bentley Motors Limited; Bentley Motors, Inc; Volkswagen AG; Volkswagen Group of America, Inc.
No confusion in trademark victory on summary judgment for the American Retirement Association
American Retirement Association
Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million
Intellia Therapeutics, Inc.
Finnegan secures favorable ITC ruling related to innovative electric SUVs for BMW
BMW of North America, LLC and Bayerische Motoren Werke AG
Finnegan fights for Sony’s “exceedingly famous” mark
Sony Group Corporation
Experience
AbbVie Inc. et al v. Alvotech hf. AbbVie Inc. et al v. Alvotech hf.
1:21-cv-02258, 1:21-cv-02899, N.D. Ill., Judge Lee
Experience
Defeating a motion for preliminary injunction in the Western District of Texas Defeating a motion for preliminary injunction in the Western District of Texas
6:20-cv-00894, -00895, -00896, -00897, W.D. Tex., Judge Albright
6:20-cv-01080, W.D. Tex., Judge Albright
IPR2021-00214, -00215, -00216; PGR2021-00010, -00090, PTAB, Judges Kalan, Ross, Kaiser
Experience
Bial - Portela & CA S.A. v. Alkem Laboratories Ltd et al. Bial - Portela & CA S.A. v. Alkem Laboratories Ltd et al.
1:18-cv-00304, D. Del., Judges Connolly, Burke
Experience
Grünenthal GmbH v. Teva Pharmaceuticals Grünenthal GmbH v. Teva Pharmaceuticals
1:12-cv-08060, S.D.N.Y., Judges Griesa, Daniels, Gorenstein
Experience
Federal Circuit win for Eli Lilly’s Xigris®, a recombinant form of human Activated Protein Federal Circuit win for Eli Lilly’s Xigris®, a recombinant form of human Activated Protein
08-1248, Fed. Cir., Judges Michel, Newman, Mayer, Lourie, Rader, Bryson, Gajarsa, Linn, Dyk, Prost, Moore
1:02-cv-11280, D. Mass., Judge Zobel
Experience
Pronova Biopharma Norge AS v. Teva Pharmaceuticals USA, Inc. Pronova Biopharma Norge AS v. Teva Pharmaceuticals USA, Inc.
1:09-cv-00286, 1:10-cv-00800, D. Del., Judges Farnan, Robinson, Thynge
12-1498, -1499, Fed. Cir., Judges Dyk, O'Malley, Wallach
Experience
Favorable Federal Circuit ruling confirms the existence of a separate written description requirement Favorable Federal Circuit ruling confirms the existence of a separate written description requirement
1:02-cv-11280, D. Mass., Judge Zobel
08-1248, Fed. Cir., Judges Bryson, Dyk, Gajarsa, Linn, Lourie, Mayer, Michel, Moore, Newman, Prost, Rader
Experience
Eli Lilly and Co. wins challenge to patents covering its osteoporosis drug, Evista® Eli Lilly and Co. wins challenge to patents covering its osteoporosis drug, Evista®
1:06-cv-01017, S.D. Ind., Judges Barker, Magnus-Stinson
09-1071; 10-1005, -1033, Fed. Cir., Judges Linn, Michel, Prost, Rader
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.